CN Patent

CN107810000A — 来氟米林的可注射药物组合物

Assigned to Marubeni Pharmaceutical Corp · Expires 2018-03-16 · 8y expired

What this patent protects

本发明涉及包含式(I)化合物的可注射药物制剂，所述制剂被缓冲至药学上可接受的pH值，特别是2至6的pH值，尤其是3至5.5的pH值，优选约4至5的pH值、特别优选约5的pH值。化合物(I)是具有抗菌性能的来氟米林(BC‑3781)。

USPTO Abstract

本发明涉及包含式(I)化合物的可注射药物制剂，所述制剂被缓冲至药学上可接受的pH值，特别是2至6的pH值，尤其是3至5.5的pH值，优选约4至5的pH值、特别优选约5的pH值。化合物(I)是具有抗菌性能的来氟米林(BC‑3781)。

Drugs covered by this patent

Patent Metadata

Patent number
CN107810000A
Jurisdiction
CN
Classification
—
Expires
2018-03-16
Drug substance claim
No
Drug product claim
No
Assignee
Marubeni Pharmaceutical Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.